AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUTRO BIOPHARMA, INC. Director's Dealing 2021

Jan 20, 2021

34319_dirs_2021-01-20_fa9b66e0-4bcf-4d42-bd0d-3804846b0733.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2021-01-19

Reporting Person: FITZPATRICK LINDA A (Chief People & Comm. Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-19	Common Stock	M	1652	$4.36	Acquired	15616	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-19	Stock Option (right to buy)	$4.36	M	1652	Disposed	2021-02-08	Common Stock (1652)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10383	Indirect

Footnotes

F1: These securities are held of record by Michael A. Fitzpatrick and Linda A. Fitzpatrick, Trustees of the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.

F2: The option is fully vested and exercisable.